Pelthos Therapeutics Inc
Price
FilingsNewest: 8-K, Director or officer changeOct 1 →Insiders1 insider bought $999,822 in 2 open-market buys. 5 insiders sold $385,404, 10 of 15 sales on a 10b5-1 plan.→HoldersAigh 8.8%Murchinson 8.2%Ikarian Capital 6.9%→Financing →PeersClosest companies: SUPN, NUVB, CHRS→
From the filings
Figures
- Revenue
- $43.3Mlast 12 months
- Net income
- −$86.4Mlast 12 months
- Operating cash flow
- −$35.1Mlast 12 months
- Cash and equivalents
- $24.2Mat the last balance sheet
- Shares outstanding
- 3.7M shareson issue